Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement

Journal of Pharmacy and Pharmacology

Volumn , Issue , 2016, Pages 980-988

  Li, Xin ^a   Yuan, Huiling ^a   Zhang, Caiyun ^a   Chen, Weidong ^a   Cheng, Weiye ^a   Chen, Xin ^a   Ye, Xi ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

curcumin; cytotoxicity; intravenous injection; nanosuspension; pharmacokinetics

Indexed keywords

CURCUMIN; NANOPARTICLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; DOSE RESPONSE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STRUCTURE; FEMALE; HEPG2 CELL LINE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MEAN RESIDENCE TIME; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RAT; SINGLE DRUG DOSE; SUSPENSION; TIMED DRUG RELEASE; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84977596464     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12575     Document Type: Article

References (42)

1. Andrade C. A critical examination of studies on curcumin for depression. J Clin Psychiatry 2014; 75: e1110–e1112.
2. Turrini E et al. Natural compounds to overcome cancer chemoresistance: toxicological and clinical issues. Expert Opin Drug Metab Toxicol 2014; 10: 1677–1690.
3. Arunraj TR et al. Synthesis, characterization and biological activities of curcumin nanospheres. J Biomed Nanotechnol 2014; 10: 238–250.
4. Kazemi-Lomedasht F et al. Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Adv Pharm Bull 2013; 3: 127–130.
5. Tønnesen HH et al. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 2002; 244: 127–135.
6. Garige M, Walters E. Curcumin inhibits development and cell adhesion in Dictyostelium discoideum: implications for YakA signaling and GST enzyme function. Biochem Biophys Res Commun 2015; 467: 275–281.
7. Lone J et al. Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes. J Nutr Biochem 2015; 27: 193–202.
8. Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules 2014; 19: 20091–20112.
9. Simion V et al. Conjugation of curcumin-loaded lipid nanoemulsions with cell-penetrating peptides increases their cellular uptake and enhances the anti-inflammatory effects in endothelial cells. J Pharm Pharmacol 2016; 68: 195–207.
10. Sareen R et al. Curcumin-Zn(II) complex for enhanced solubility and stability: an approach for improved delivery and pharmacodynamic effects. Pharm Dev Technol 2016; 21: 630–635.
11. Manju S, Sreenivasan K. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells. J Colloid Interface Sci 2012; 368: 144–151.
12. Fares MM, Salem MS. Dissolution enhancement of curcumin via curcumin-prebiotic inulin nanoparticles. Drug Dev Ind Pharm 2015; 41: 1785–1792.
13. Ji H et al. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Drug Deliv 2016; 23: 459–470.
14. Chen Y et al. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo. Drug Deliv 2016; 23: 1383–1392.
15. Huang X et al. Solid lipid nanoparticles as delivery systems for Gambogenic acid. Colloids Surf B Biointerfaces 2013; 102: 391–397.
16. Yang X et al. Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo. Sci Rep 2015; 5: 10322.
17. Yang H et al. Investigation of a nanosuspension stabilized by Soluplus (R) to improve bioavailability. Int J Pharm 2014; 477: 88–95.
18. Shi S et al. Chitosan grafted methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac. Sci Rep 2015; 5: 11337.
19. Ahuja BK et al. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Int J Pharm 2015; 478: 540–552.
20. Leung DH et al. A new and improved method for the preparation of drug nanosuspension formulations using acoustic mixing technology. Int J Pharm 2014; 473: 10–19.
21. Leng D et al. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size. Int J Pharm 2014; 472: 380–385.
22. Zu Y et al. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique. Int J Pharm 2014; 471: 366–376.
23. Aditya NP et al. Fabrication of amorphous curcumin nanosuspensions using beta-lactoglobulin to enhance solubility, stability, and bioavailability. Colloids Surf B Biointerfaces 2015; 127: 114–121.
24. Gao Y et al. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev Ind Pharm 2010; 36: 1225–1234.
25. Wei XL et al. Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: preparation, characterization and in vivo evaluation. Eur J Pharm Sci 2013; 49: 286–293.
26. Chin WW et al. A brief literature and patent review of nanosuspensions to a final drug product. J Pharm Sci 2014; 103: 2980–2999.
27. Taneja S et al. Formulation and optimization of efavirenz nanosuspensions using the precipitation-ultrasonication technique for solubility enhancement. Artif Cells Nanomed Biotechnol 2016; 44: 978–984.
28. Gao Y et al. Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv 2011; 18: 131–142.
29. Gao Y et al. In vivo evaluation of curcumin loaded nanosuspensions by oral administration. J Biomed Nanotechnol 2012; 8: 659–668.
30. Rachmawati H et al. Development of curcumin nanocrystal: physical aspects. J Pharm Sci 2013; 102: 204–214.
31. -PO solid dispersion: a simple and potent method to solve the problems of curcumin. Eur J Pharm Biopharm 2015; 94: 322–332.
32. Snyder RW et al. Distribution and biomarker of carbon-14 labeled fullerene C60 ([(14) C(U)]C60) in pregnant and lactating rats and their offspring after maternal intravenous exposure. J Appl Toxicol 2015; 35: 1438–1451.
33. Meeus J et al. In vivo evaluation of different formulation strategies for sustained release injectables of a poorly soluble HIV protease inhibitor. J Control Release 2015; 199: 1–9.
34. Margulis K et al. Formation of curcumin nanoparticles by flash nanoprecipitation from emulsions. J Colloid Interface Sci 2014; 434: 65–70.
35. Lestari ML et al. Systematic screening of different surface modifiers for the production of physically stable nanosuspensions. J Pharm Sci 2015; 104: 1128–1140.
36. Kumar SS et al. Curcumin loaded poly(2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid–in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells. Eur J Pharm Sci 2014; 51: 34–44.
37. Hao J et al. Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design. AAPS PharmSciTech 2015; 16: 118–128.
38. Neves AR et al. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int J Nanomedicine 2013; 8: 177–187.
39. Shah B et al. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. J Pharm Sci 2006; 95: 1641–1665.
40. Kumar A et al. Curcumin loaded nano globules for solubility enhancement: preparation, characterization and ex vivo release study. J Nanosci Nanotechnol 2012; 12: 8293–8302.
41. Pan K et al. Enhanced dispersibility and bioactivity of curcumin by encapsulation in casein nanocapsules. J Agric Food Chem 2013; 61: 6036–6043.
42. Manju S et al. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J Colloid Interface Sci 2011; 359: 318–325.